E
Endpoint provides an AI-powered platform for generating Real-World Evidence (RWE) studies quickly. The platform leverages a network of over 25 million multimodal, longitudinal patient records to deliver instant insights across various therapeutic areas. This capability supports researchers and pharmaceutical companies in areas like comparative effectiveness, label expansion, and trial design.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Endpoint provides an AI-powered platform for generating Real-World Evidence (RWE) studies quickly. The platform leverages a network of over 25 million multimodal, longitudinal patient records to deliver instant insights across various therapeutic areas. This capability supports researchers and pharmaceutical companies in areas like comparative effectiveness, label expansion, and trial design.